glp-1 agonist prediabetes GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome Frontiers | GLP−1 receptor agonists
Description
It should be noted that physiologic GLP-1R agonism in the periphery mediates food intake reduction via vagal afferent signaling as rats with a surgical subdiaphragmatic vagal deafferentation (SDA) exhibit a more mild food intake suppression in response to acute administration of GLP-1 analogues than sham operated animals (80, 81)
Rodriguez PJ et al
Food and Drug Administration (FDA) has approved the first GLP-1 weight-loss pill, a tablet formulation of semaglutide
Our idea of bedtime reading
K.SinghR
